Literature DB >> 25433416

Oral propranolol and intravitreal ranibizumab for refractory serous macular detachment secondary to retinal capillary hemangioblastoma.

P Hernández-Martínez1, R Gallego-Pinazo2, R Dolz-Marco3, J F Arevalo4, M Díaz-Llopis3, A Cisneros Lanuza2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25433416     DOI： 10.1016/j.oftal.2014.01.007

Source DB:  PubMed          Journal:  Arch Soc Esp Oftalmol        ISSN： 0365-6691


× No keyword cloud information.
  2 in total

1.  Treatment of juxtapapillary hemangioblastoma by intra-arterial (ophthalmic artery) chemotherapy with bevacizumab.

Authors:  Jasmine H Francis; Jason S Slakter; David H Abramson; Steven A Odrich; Y Pierre Gobin
Journal:  Am J Ophthalmol Case Rep       Date:  2018-05-24

2.  Regression of primary cardiac angiosarcoma and metastatic nodules following propranolol as a single agent treatment.

Authors:  Dana C Galván; Anoop P Ayyappan; Brad A Bryan
Journal:  Oncoscience       Date:  2018-10-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.